Clinical benefit of neoadjuvant chemoradiotherapy for the avoidance of pneumonectomy; assessment in 12 consecutive centrally located non-small cell lung cancers

No abstract is available for this paper.

• Publication year

  2017

• Venue

  General Thoracic and Cardiovascular Surgery

• Publication date

  2017-04-21

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s11748-017-0776-yPMID 28432576
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Thoracic and cardiovascular surgery in Japan during 2014

  2016cited by this paper
• Relationship Between Radiation Therapy Dose and Outcome in Patients Treated With Neoadjuvant Chemoradiation Therapy and Surgery for Stage IIIA Non-Small Cell Lung Cancer: A Population-Based, Comparative Effectiveness Analysis.

  2015cited by this paper
• An analysis, systematic review, and meta-analysis of the perioperative mortality after neoadjuvant therapy and pneumonectomy for non-small cell lung cancer.

  2012cited by this paper
• Japanese Lung Cancer Registry Study of 11,663 Surgical Cases in 2004: Demographic and Prognosis Changes Over Decade

  2011cited by this paper
• Pneumonectomy is a valuable treatment option after neoadjuvant therapy for stage III non-small-cell lung cancer.

  2010cited by this paper
• Predictors of major morbidity and mortality after pneumonectomy utilizing the Society for Thoracic Surgeons General Thoracic Surgery Database.

  2010cited by this paper
• Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial.

  2009cited by this paper
• Concurrent cisplatin/etoposide plus 3D-conformal radiotherapy followed by surgery for stage IIB (superior sulcus T3N0)/III non-small cell lung cancer yields a high rate of pathological complete response.

  2008cited by this paper
• Multimodality treatment of unresectable stage III non-small cell lung cancer: interim analysis of a phase II trial with preoperative gemcitabine and concurrent radiotherapy.

  2006cited by this paper
• Pneumonectomy after high-dose radiation and concurrent chemotherapy for nonsmall cell lung cancer.

  2006cited by this paper
• Low morbidity and mortality for bronchoplastic procedures with and without induction therapy.

  2005cited by this paper
• Local control of disease related to lymph node involvement in non-small cell lung cancer after sleeve lobectomy compared with pneumonectomy.

  2005cited by this paper
• Pulmonary resection after high-dose and low-dose chest irradiation.

  2005cited by this paper
• Pulmonary resection after curative intent radiotherapy (>59 Gy) and concurrent chemotherapy in non-small-cell lung cancer.

  2004cited by this paper
• Sleeve lobectomy versus pneumonectomy for lung cancer: a comparative analysis of survival and sites or recurrences.

  2004cited by this paper
• Parenchymal sparing operations for bronchogenic carcinoma.

  2002cited by this paper
• Extended sleeve lobectomy for lung cancer: the avoidance of pneumonectomy.

  1999cited by this paper
• Preoperative chemotherapy followed by concurrent chemoradiation therapy based on hyperfractionated accelerated radiotherapy and definitive surgery in locally advanced non-small-cell lung cancer: mature results of a phase II trial.

  1998cited by this paper
• The postpneumonectomy state.

  1998cited by this paper
• Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for stages IIIA (N2) and IIIB non-small-cell lung cancer: mature results of Southwest Oncology Group phase II study 8805.

  1995cited by this paper
• Preoperative chemotherapy and radiation therapy for stage IIIa carcinoma of the lung.

  1992cited by this paper

• Pneumonectomy for Primary Lung Tumors and Pulmonary Metastases: A Comprehensive Study of Postoperative Morbidity, Early Mortality, and Preoperative Clinical Prognostic Factors

  2023cites this paper
• Primary tumor location in lung cancer: the evaluation and administration

  2021cites this paper
• Bronchoplasties at the Segmental Level.

  2018cites this paper